Study Summary: This study looks at how well two treatments work for people with middle to late-stage liver cancer. One treatment is called TACE (Transarterial Chemoembolization), which is a way to deliver cancer-fighting drugs directly to the liver. The study is comparing TACE used alone to TACE combined with immunotherapy (which helps your immune system fight cancer) and targeted therapy (which focuses on specific cancer cells). Researchers want to see which treatment is safer and more effective. Key Points:

• The study only looks at past treatment data, so no new treatments are given.
• Participants must have good liver function and be in good health overall.
• People with other serious illnesses or certain past medical conditions cannot be included.

If you are 18 or older and have liver cancer confirmed by tests, you might fit the study. However, if you have other health issues like severe heart disease, infections, or mental illness, you might not qualify. This study helps doctors understand the best ways to treat liver cancer.